PHP
XFOR icon

Parkman Healthcare Partners’s X4 Pharmaceuticals XFOR Stock Holding History

Parkman Healthcare Partners’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,291
Closed -$548K – 101
2024
Q3 		$548K Buy
27,291
+404
+2% +$8.43K 0.07% 89
2024
Q2 		$468K Buy
26,887
+42
+0.2% +$1.37K 0.06% 87
2024
Q1 		$1.12M Buy
26,845
+1,267
+5% +$35.3K 0.14% 91
2023
Q4 		$643K Sell
25,578
-1,089
-4% -$26.5K 0.09% 86
2023
Q3 		$872K Sell
26,667
-98,886
-79% -$4.31M 0.16% 92
2023
Q2 		$7.31M Buy
125,553
+32,315
+35% +$1.66M 1.27% 26
2023
Q1 		$2.43M Buy
93,238
+14,053
+18% +$412K 0.53% 52
2022
Q4 		$2.36M Buy
79,185
+47,518
+150% +$2.25M 0.63% 53
2022
Q3 		$1.63M Buy
+31,667
New +$1.09M 0.46% 63

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return